Demand in the biotechnology contract manufacturing market is rising due to demand for biologics in medicine. Biologics contract manufacturers know how to make these therapies more effective with ease of use. Also, they ensure adherence to strict quality rules and regulations. They have a deep understanding of cell structure, downstream process, protein chemistry and its impact on yield and protein structure while forwarding from lab to GMP scale. Hence, biopharmaceutical companies prefer to go for highly efficient way to increase development and manufacturing by partnering with CDMOs, and CMOs. As they have strong expertise in biologics and commercial manufacturing. However, saving and protecting intellectual property can be a concern for companies. It includes the risk of using the patented information in an unauthorized way that creates a barrier to markets growth.
Although, increasing demand for cell and gene therapies are creating significant impact on the market, since gene and cell therapies are highly specific and hold potential to explore unidentified medical needs, further creating lucrative opportunities for the biotechnology contract manufacturing market on a global scale.
Download
Order Databook
Actionable Solutions
